Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.45 |
| ▸ | PGK1 | P00558 | 4/20 | 0.44 |
| ▸ | PGK2 | P07205 | 4/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | MMP12 | P39900 | 2/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28872215 | 0.87 | GABRA1 (0.52) | ACP3SMN1; SMN2GABRA1GABRB2PGK1 | |
| SCHEMBL14732169 | 0.85 | ACP3 (0.46) | ACP3SMN1; SMN2GABRA1GABRB2GRIN2D | |
| SCHEMBL17223188 | 0.82 | PPARD (0.40) | ACP3SMN1; SMN2GABRA1GABRB2 | |
| SCHEMBL11499183 | 0.81 | ACP3 (0.57) | ACP3SMN1; SMN2GABRA1GABRB2GRIN2D | |
| SCHEMBL7263777 | 0.81 | GABRA1 (0.42) | ACP3SMN1; SMN2GABRA1GABRB2 | |
| SCHEMBL245773 | 0.80 | GABRA1 (0.57) | GABRA1GABRB2 | |
| SCHEMBL12197606 | 0.78 | ACP3 (0.46) | ACP3SMN1; SMN2GABRA1GABRB2GRIN2D | |
| SCHEMBL31498538 | 0.78 | GABRA1 (0.55) | GABRA1GABRB2 | |
| Methane SCHEMBL28776675 | 0.78 | GABRA1 (0.55) | GABRA1GABRB2 | |
| Ammonia Solution, Strong SCHEMBL27320869 | 0.78 | GABRA1 (0.55) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3592735-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TETROFOSMIN OR ACID ADDITION SALT THEREOF | JUBILANT GENERICS LTD FORMERLY A DIVISION OF JUBILANT LIFE SCIENCES LTD (IN) | 2024-03-20 | — | — | EP | claimed |
| CN-116249520-A | Blocking replication of SARS-COV-2 and other pathogenic viruses using WNT/beta-catenin pathway inhibitors | 阿尔伯塔大学理事会 | 2023-06-09 | — | — | CN | claimed |
| CN-113707933-A | Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid | 北京卫蓝新能源科技有限公司 | 2021-11-26 | — | — | CN | claimed |
| US-10836781-B2 | Process for the preparation of tetrofosmin or acid salt thereof | Jubilant Generics Limited (IN) | 2020-11-17 | — | — | US | claimed |
| EP-2719496-B1 | FLUX | SENJU METAL INDUSTRY CO (JP) | 2018-09-26 | — | — | EP | claimed |
| WO-2018162964-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TETROFOSMIN OR ACID ADDITION SALT THEREOF | JUBILANT GENERICS LIMITED (FORMERLY A DIVISION OF JUBILANT LIFE SCIENCES LIMITED) (IN) | 2018-09-13 | — | — | WO | claimed |
| US-9227187-B2 | Method for preparing proton-conducting inorganic particles | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2016-01-05 | — | — | US | claimed |
| US-20140113982-A1 | METHOD FOR PREPARING PROTON-CONDUCTING INORGANIC PARTICLES | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2014-04-24 | — | — | US | claimed |
| EP-2647013-A1 | METHOD FOR PREPARING PROTON CONDUCTING INORGANIC PARTICLES | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2013-10-09 | — | — | EP | claimed |
| WO-2012072572-A1 | METHOD FOR PREPARING PROTON CONDUCTING INORGANIC PARTICLES | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2012-06-07 | — | — | WO | claimed |
| EP-4269543-B1 | POLYSILOXANE HYDRAULIC FLUIDS | COMMW SCIENT IND RES ORG (AU) | 2026-03-04 | — | — | EP | disclosed |
| WO-2025133100-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE PREPARATION OF TAPINAROF | INTERQUIM, S.A. (ES) | 2025-06-26 | — | — | WO | disclosed |
| US-12227713-B2 | Polysiloxane hydraulic fluids | THE BOEING COMPANY (US) | 2025-02-18 | — | — | US | disclosed |
| US-20250011671-A9 | POLYSILOXANE HYDRAULIC FLUIDS | THE BOEING COMPANY | 2025-01-09 | — | — | US | disclosed |
| US-12159967-B2 | Nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-12-03 | — | — | US | disclosed |
| US-4892949-A | ORGANIC PHOTOCONDUCTORS | RICOH COMPANY, LTD. (JP) | 1990-01-09 | — | — | US | disclosed |
| US-4859556-A | MULTILAYER; ELECTROCONDUCTIVE SUPPORT WITH PHOTOSENSITIVE MATERIAL | RICOH COMPANY, LTD. (JP) | 1989-08-22 | — | — | US | disclosed |
| EP-0068378-B1 | NOVEL IMIDAZO(1,2-A)PYRIDINES AND PYRAZINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING CORPORATION (US) | 1986-03-05 | — | — | EP | disclosed |
| US-4450164-A | ANTIULCER AND ANTISECRETORY AGENTS | SCHERING CORPORATION (US) | 1984-05-22 | — | — | US | disclosed |
| EP-0068378-A1 | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1983-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10836781-B2 | Process for the preparation of tetrofosmin or acid salt thereof | SLC6A3, SLC6A5, SLC6A6 | ACP3 3412/4885SMN1; SMN2 1938/4885GABRA1 1503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.